| Literature DB >> 33041743 |
Stephan Rogalla1, Krzysztof Flisikowski2, Dimitris Gorpas3, Aaron T Mayer1, Tatiana Flisikowska2, Michael J Mandella1, Xiaopeng Ma3, Kerriann M Casey4, Stephen A Felt4, Dieter Saur5, Vasilis Ntziachristos3, Angelika Schnieke2, Christopher H Contag6, Sanjiv S Gambhir1, Stefan Harmsen1.
Abstract
Early and comprehensive endoscopic detection of colonic dysplasia - the most clinically significant precursor lesion to colorectal adenocarcinoma - provides an opportunity for timely, minimally-invasive intervention to prevent malignant transformation. Here, the development and evaluation of biodegradable near-infrared fluorescent silica nanoparticles (FSN) is described that have the potential to improve adenoma detection during fluorescence-assisted white-light colonoscopic surveillance in rodent and human-scale models of colorectal carcinogenesis. FSNs are biodegradable (t1/2 of 2.7 weeks), well-tolerated, and enable detection and delineation of adenomas as small as 0.5 mm2 with high tumor-to-background ratios. Furthermore, in the human-scale, APC 1311/+ porcine model, the clinical feasibility and benefit of using FSN-guided detection of colorectal adenomas using video-rate fluorescence-assisted white-light endoscopy is demonstrated. Since nanoparticles of similar size (e.g., 100-150-nm) or composition (i.e., silica, silica/gold hybrid) have already been successfully translated to the clinic, and, clinical fluorescent/white light endoscopy systems are becoming more readily available, there is a viable path towards clinical translation of the proposed strategy for early colorectal cancer detection and prevention in high-risk patients.Entities:
Keywords: Biodegradable; colorectal lesions; endoscopy; fluorescent nanoparticles; imaging
Year: 2019 PMID: 33041743 PMCID: PMC7546531 DOI: 10.1002/adfm.201904992
Source DB: PubMed Journal: Adv Funct Mater ISSN: 1616-301X Impact factor: 18.808